ArchivesMagazine - 14 Aug 2025Eli Lilly shares under pressure after disappointing clinical trial results Rival Novo Nordisk has already submitted its oral obesity pill for US approval 14 August 2025|News|by Martin Gamble Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email < Twenty-five years after the first one launched in the UK how have ETFs changed? Recruiter Hays set to update expectations with shares at decade-low > Issue: 14 Aug 2025 - Page 8 | Contents Next: Recruiter Hays set to update expectations with shares at decade-low Previous: Twenty-five years after the first one launched in the UK how have ETFs changed? Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email Martin Gamble Issue Contents Ask Rachel How can I avoid falling foul of HMRC recycling rules? Editor's View Meet the new UK market addition which is set to join the FTSE 100 soon Exchange-Traded Funds Twenty-five years after the first one launched in the UK how have ETFs changed? Feature Fund managers’ forever stocks How to exploit analysts’ least loved stocks using earnings revisions Why volatility isn’t just a mental drain but a money drain too Great Ideas Buy AVI Global to take advantage of its double discount Anpario can nourish portfolios with growth and income Why we believe investors should stay invested in Oracle News Record numbers of US companies are beating revenue and earnings forecasts Bellway brings a ray of light to the housebuilders with its half-year update Eli Lilly shares under pressure after disappointing clinical trial results Fresnillo up 180% year-to-date after latest strong results Recruiter Hays set to update expectations with shares at decade-low All eyes on second-quarter retail bellwether Walmart Personal Finance How to cope with a cruel summer of speculation
